Health
Foresight Diagnostics demonstrates the benefits of PhasED-Seq technology at the ICML meeting – News-Medical.Net – Fior Reports
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical…
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical performance of its Minimal Residual Disease Detection Platform (MRD) in Diffuse B-Cell Large Cell Lymphoma (DLBCL) will be presented…
Continue Reading
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoWest End icon closes doors
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire